Clinical trials
Active, not recruiting Phase 2 Parkinson Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 2 |
| AC Immune SA | 1 |
| Aptinyx | 1 |
| AskBio Inc | 1 |
| Bial R&D Investments, S.A. | 1 |
| Cedars-Sinai Medical Center | 1 |
| Denali Therapeutics Inc. | 1 |
| Fundacion Clinic per a la Recerca Biomédica | 1 |
| Il-Yang Pharm. Co., Ltd. | 1 |
| Michele Tagliati, MD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Parkinson Disease | 18 |
| Movement Disorders | 3 |
| Neurodegenerative Diseases | 3 |
| REM Sleep Behavior Disorder | 3 |
| Central Nervous System Diseases | 2 |
| Nerve Degeneration | 2 |
| Parkinson Disease, Secondary | 2 |
| Primary Dysautonomias | 2 |
| Basal Ganglia Diseases | 1 |
| Cognitive Dysfunction | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.